Filing Details

Accession Number:
0001179110-18-011179
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-06 19:02:37
Reporting Period:
2018-09-04
Accepted Time:
2018-09-06 19:02:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419579 Anne-Marie Duliege Rigel Pharmaceuticals, Inc.
1180 Veterans Boulevard
South San Francisco CA 94080
Evp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-04 16,500 $2.54 16,500 No 4 M Direct
Common Stock Disposition 2018-09-04 16,500 $3.51 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employe Stock Option (right to buy) Disposition 2018-09-04 16,500 $0.00 16,500 $2.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
383,500 2026-05-05 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018.
  2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $3.50 to $3.53. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the shares sold at each such separate price.
  3. One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months.